Advances in Medicine and Biology. Volume 107

(sharon) #1
Childhood Obesity in the United Kingdom 119

[40] Make it count. http://nhfshare.heartforum.org.uk/RMAssets/Casestudies/
Walsall_Make_it_Count.pdf. Last accesses 11th May 2016.
[41] Snack Right. http://nhfshare.heartforum.org.uk/RMAssets/Casestudies/
PP_Snack_Right.pdf. Last accessed 11th May 2016.
[42] Food and Drug Administration. Guidance for Industry Developing
Products for Weight Management. February 2007. http://www.fda.gov/
downloads/Drugs/.../Guidances/ucm071612.pdf Last accessed on 30
June 2016.
[43] Lenders CM. 2015. ‘Paediatric obesity: can medications help?’ Curr
Opin Endocrinol Diabetes Obes. 22:331-39.
[44] National Institute for Health and Clinical Excellence. Obesity:
identification, assessment and management. November. 2014.
https://www.nice.org.uk/guidance/cg189/chapter/1-recommendations.
Last accessed on 29th June 2016.
[45] Scottish Intercollegiate Guidelines Network. Management of Obesity: A
national clinical guideline. Edinburgh. 2010. http://www.sign.ac.uk/pdf/
qrg115.pdf. Last accessed 29th June 2016.
[46] W. Philip T. James, M.D., D.Sc., Ian D. Caterson, M.D., Ph.D., Walmir
Coutinho, M.D., D.Sc., Nick Finer, M.B., B.S., Luc F. Van Gaal, M.D.,
Ph.D., Aldo P. Maggioni, M.D., Christian Torp-Pedersen, M.D., Ph.D.,
Arya M. Sharma, M.D., Ph.D., Gillian M. Shepherd, B.Sc., Richard A.
Rode, Ph.D., and Cheryl L. Renz, M.D., for the SCOUT Investigators.



  1. ‘Effect of sibutramine on cardiovascular outcomes in overweight
    and obese subject’s. N Engl J Med. 363:905-917.
    [47] Boland CL, Harris JB, Harris KB. 2015. ‘Pharmacological management
    of obesity in paediatric patients’. Ann Pharmacother. 49(2);220-32.
    [48] Medicines and Healthcare Products Regulatory Agency. 2014 October.
    Public Assessment Report. Orlistat Mylan 60mg capsules, hard.
    [49] Petkar R, Wright N. 2013. Pharmacological management of obese child.
    Arch Dis Child Edu Pract Ed. 98(3):108-12.
    [50] Medicines and Healthcare Products Regulatory Agency. Orlistat safety
    update. February 2010. https://www.gov.uk/drug-safety-update/orlistat-
    safety-update. Last accessed 29th May 2016.
    [51] Rogovik AL, Goldman RD. 2011. ‘Pharmacological treatment of
    paediatric obesity’. Can Fam Physician. 57(2):195-7.
    [52] Viner RM, Hsia Y, Tomsic T, Wong I. C. K. 2010. ‘Efficacy and safety
    of anti-obesity drugs in children and adolescents: systematic review and
    meta-analysis’. Obes Rev 11:593–602.

Free download pdf